Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MicroRNA signatures in genetic frontotemporal dementia and amyotrophic lateral sclerosis

20 Oct 2022

Abstract excerpt

OBJECTIVE: MicroRNAs are promising biomarkers of frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS), but discrepant results between studies have so far hampered their use in clinical trials. We aim to assess all previously identified circulating microRNA signatures as potential biomarkers of genetic FTD and/or ALS, using homogeneous, independent validation cohorts of C9orf72 and GRN mutation...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyotrophic Lateral Sclerosis Research
Share to MicroRNA in disease regulation
Share to Neuroinflammation and Neurodegeneration Mechanisms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36264717
DOI: 10.1002/acn3.51674

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MicroRNA signatures in genetic frontotemporal dementia and amyotrophic lateral sclerosisPMID 36264717Read ↗

Plasma microRNA signature in presymptomatic and symptomatic subjects with C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis.Semantic proximity Read ↗

Long Non-Coding RNA Profile in Genetic Symptomatic and Presymptomatic Frontotemporal Dementia: A GENFI Study.Semantic proximity Read ↗

Downregulation of exosomal miR-204-5p and miR-632 as a biomarker for FTD: a GENFI studySemantic proximity Read ↗

MicroRNAs as Biomarkers in Amyotrophic Lateral SclerosisSemantic proximity Read ↗

Serum microRNAs in sporadic amyotrophic lateral sclerosis.Semantic proximity Read ↗

microRNA‐based predictor for diagnosis of frontotemporal dementiaSemantic proximity Read ↗

An Overview of MicroRNAs as Biomarkers of ALSSemantic proximity Read ↗

Circulating Non-Coding RNA Levels Are Altered in Autosomal Dominant Frontotemporal Dementia.Semantic proximity Read ↗

Machine learning to detect Alzheimer’s disease from circulating non-coding RNAsSemantic proximity Read ↗

Serum microRNAs in patients with genetic amyotrophic lateral sclerosis and pre-manifest mutation carriers.Semantic proximity Read ↗

Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseasesSemantic proximity Read ↗

MicroRNAs in amyotrophic lateral sclerosis: from pathogenetic involvement to diagnostic biomarker and therapeutic agent developmentSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.